Studies

ID Name Disease Status
FLIPPER   renal cell carcinoma
 active
AMLSG 17-10
CIARA 		acute myeloid leukemia
 active
MARC-2   Everolimus in patients with metastatic RCC after VEGF-targeted therapy failure renal cell carcinoma
 active
MC-PEGASP.1/adults   PEG-rASNase bei GMALL 7/2003 Patienten acute lymphoblastic leukemia
 active
MT 103-203   BiTE antibody blinatumomab in adult patients with MRD of B-precursor ALL acute lymphoblastic leukemia
 active
CRAD001CDE21T
KS-2009-002 		Everolimus for patients with relapsed/refractory germ cell cancer (RADIT) testicular cancer
 active
ICRAT   InductionChemo-Radio-Antibody-Treatment Hypopharynxkarzinom
Oropharynxkarzinom
 active
CSTI571BDE70   Desmoidstudie Aggressive Fibromatose
 active
HD16   First-line treatment in Hodgkin lymphoma Hodgkin's lymphoma
 active
CC-5013-MDS-005   Lenalidomid vs. Placebo in MDS patients without deletion 5q myelodysplastic syndrome
 active
CeFCID   Cetuximab, cisplatin, 5-FU ± docetaxel Hypopharynxkarzinom
Larynxkarzinom
Nasennebenhöhlenkarzinom
Oropharynxkarzinom
Plattenepithelkarzinom der Haut
Zungenkarzinom
 active
AMLSG 09-09   ATRA ± gemtuzumab in patients with AML and NPM1 gene mutation acute myeloid leukemia
 active
PACET-CUP   Paclitaxel/carboplatin +/- cetuximab in carcinoma of unknown primary various active
BUM-5/GVH   Budesonide in oral chronic GvHD various active
NHL 7 - 2008   Rituximab Erhaltungstherapie bei indolenten Lymphomen (MAINTAIN) follicular lymphoma (grade I-II)
immunocytoma
mantle cell lymphoma
marginal zone lymphoma
 active